<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CPJ</journal-id>
<journal-id journal-id-type="hwp">spcpj</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Pediatr (Phila)</journal-id>
<journal-title>Clinical Pediatrics</journal-title>
<issn pub-type="ppub">0009-9228</issn>
<issn pub-type="epub">1938-2707</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0009922811398962</article-id>
<article-id pub-id-type="publisher-id">10.1177_0009922811398962</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Life-Threatening Cytomegalovirus Enteritis and Pneumonia in an Immunocompetent Adolescent</article-title>
<subtitle>A Case Report and Brief Literature Review</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Freeman</surname><given-names>A. Jay</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922811398962">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bishop</surname><given-names>Phyllis R.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922811398962">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Subramony</surname><given-names>Charu</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922811398962">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Nowicki</surname><given-names>Michael J.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922811398962">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0009922811398962"><label>1</label>University of Mississippi Health Center, Jackson, MS, USA</aff>
<author-notes>
<corresp id="corresp1-0009922811398962">Michael J. Nowicki, Division of Pediatric Gastroenterology, University of Mississippi Health Center, 2500 North State Street, Jackson, MS 39216, USA Email: <email>mnowicki@umc.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>51</volume>
<issue>5</issue>
<fpage>507</fpage>
<lpage>511</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<sec id="section1-0009922811398962" sec-type="intro">
<title>Introduction</title>
<p>Cytomegalovirus (CMV) is a nearly ubiquitous human pathogen in the herpes virus family that has been reported to be infectious in up to 100% of adults by the age of 30 years.<sup><xref ref-type="bibr" rid="bibr1-0009922811398962">1</xref></sup> The majority of CMV infections occur in the perinatal period, infancy, or early adulthood and are asymptomatic or present as a mononucleosis-like syndrome<sup><xref ref-type="bibr" rid="bibr2-0009922811398962">2</xref></sup> with gastrointestinal (GI) disease being exceedingly rare.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> However, severe infections are known to present in immunocompromised patients, with GI manifestations being among the most commonly reported.<sup><xref ref-type="bibr" rid="bibr4-0009922811398962">4</xref></sup> Patients with primary immune deficiencies, AIDS, organ transplantation, chemotherapy, and prolonged steroid use have all been shown to be at increased risk for CMV infection, particularly CMV colitis.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> It was believed that CMV colitis in the immunocompetent patient was an extremely rare occurrence, but recent literature suggests the prevalence is higher than previously suspected, although the incidence in the pediatric population remains sparse.</p>
</sec>
<sec id="section2-0009922811398962" sec-type="cases">
<title>Case Report</title>
<p>A 16-year-old Native American female with no significant past medical history presented as a transfer from an outside community hospital with a 3-week history of vomiting and diarrhea. During this time she also reported diffuse, colicky abdominal pain, anorexia, weight loss (12 kg), and decreased energy. She had been evaluated twice at a local clinic and was diagnosed with gastroenteritis. Because of persistent symptoms, she was admitted to the community hospital for treatment of dehydration. Initial laboratory studies were normal, including complete blood count, liver panel, and coagulation studies. Despite aggressive fluid support the patient developed worsening dehydration prompting transfer to the pediatric intensive care unit at our institution.</p>
<p>On arrival the patient appeared ill. Vital signs showed tachycardia (heart rate 117) and mild hypertension (135/78 mm Hg). Mucous membranes were tacky. Cardiovascular exam showed no murmur. The abdominal exam showed a protuberant abdomen with active bowel sounds, diffuse pain to palpation without guarding or rebound, and no organomegaly. Rectal exam showed no fissure, fistulae, or tags; there was a copious amount of liquid stool that was occult blood positive. Admission laboratory studies included serum electrolytes, liver panel, urine pregnancy test, and stool studies (bacterial culture, enterovirus culture, Clostridium difficile toxins A and B, Cryptosporidium antigen, Giardia antigen, Rotavirus antigen) were normal. Complete blood count showed normal white blood cell count (8900/mm<sup>3</sup>) and platelet count (231 000/mm<sup>3</sup>); there was a mild microcytic anemia (hemoglobin 9.8 g/dL; hematocrit 29.5%; mean corpuscular volume 73.9 fL). The stool contained numerous white blood cells. The patient received intravenous fluids, anti-emetics, and pantoprazole for ulcer prophylaxis. Her condition improved overnight and she was transferred to the general floor. She was started on nitazoxanide empirically, resulting in a decrease in diarrhea, improved appetite, and resolution of emesis. However, she developed cough and fever; a chest X-ray revealed pneumonia, for which she was started on antibiotic therapy with ceftriaxone and azithromycin. On the third day of admission, the patient had worsening diarrhea with return of abdominal pain and vomiting. Repeat laboratory studies showed no significant changes in serum electrolytes or complete blood count. A liver panel revealed evidence of hepatitis with elevation of AST (246 U/L) and ALT (224 U/L). An abdominal ultrasound showed mild hepatosplenomegally and findings consistent with mild fatty liver. Further investigation for an etiology of both diarrhea and hepatitis included testing for CMV. Stool culture for CMV and antibody to CMV (IgG and IgM) were positive, whereas quantitative polymerase chain reaction and urine culture for CMV were negative. The patient continued to have diarrhea and abdominal pain complicated by transient hyponatremia. Because of persistent diarrhea of unclear etiology esophagogastroduodenoscopy and colonoscopy were performed, revealing grossly normal appearing mucosa (<xref ref-type="fig" rid="fig1-0009922811398962">Figure 1</xref>). However, biopsies revealed CMV inclusions in the esophagus, gastric fundus, and duodenal bulb (<xref ref-type="fig" rid="fig2-0009922811398962">Figure 2</xref>). Her abdominal pain and diarrhea persisted, necessitating continued intravenous fluids and slow advancement of oral feeding.</p>
<fig id="fig1-0009922811398962" position="float">
<label>Figure 1.</label>
<caption><p>Endoscopic findings</p>
<p>The mucosa of the esophagus (A), stomach (B), and duodenum (C) appeared normal grossly.</p></caption>
<graphic xlink:href="10.1177_0009922811398962-fig1.tif"/>
</fig>
<fig id="fig2-0009922811398962" position="float">
<label>Figure 2.</label>
<caption><p>Histological findings at endoscopy</p>
<p>A, The esophageal biopsy showed chronic esophagitis with submucosal cells containing intranuclear inclusions consistent with cytomegalovirus (CMV) cytopathic effect. B, Immunohistochemical stain for CMV was positive. C, The gastric body showed moderately severe active chronic gastritis with numerous gastric epithelial cells and one stromal cell containing intranuclear inclusions consistent with CMV cytopathic effect. D, The duodenum showed chronic duodenitis with moderate villous atrophy. One Brunner’s gland epithelial cell contained intranuclear and cytoplasmic inclusions consistent with CMV cytopathic effect. The arrow points to CMV inclusions.</p></caption>
<graphic xlink:href="10.1177_0009922811398962-fig2.tif"/>
</fig>
<p>On the 23rd day of admission, the patient experienced acute deterioration in clinical status manifested by high grade fever (<italic>T</italic><sub>max</sub> = 103°F), respiratory distress, decreased oxygen saturation, hyponatremia, and metabolic acidosis. She was transferred to the intensive care unit and started on intravenous gancyclovir. Symptoms did not improve significantly, and on the 30th day of admission the patient developed worsening respiratory distress with increasing oxygen requirement requiring intubation and mechanical ventilation. A repeat chest X-ray revealed pneumonia and broad spectrum antibiotic coverage with vancomycin and levofloxacin was initiated. Bronchosopy was performed; bronchial lavage cultures grew CMV. The patient showed slow clinical improvement, was extubated, and transferred to the general ward. GI symptoms slowly resolved and the patient was able to tolerate a full diet.</p>
<p>An evaluation for an underlying immunodeficiency was undertaken. Laboratory studies included human immunodeficiency virus antibody (negative), quantitative immunoglobulins (IgG 3190 mg/dL [normal 700-1600 mg/dL], IgA 408 mg/dL [normal 70-400 mg/dL], IgM 432 mg/dl [normal 40-230 mg/dL]), CH50 (normal), white blood cells (6100/mm<sup>3</sup>, 54% segmented neutrophils, 30% lymphocytes, 14% monocytes, 1% eosinophils, and 1% basophils). T-cell subsets revealed a decrease in CD4 counts (16%, normal 37% to 48%), an increase in CD8 counts (59%, normal 25% to 31%), and a decrease in the CD4:CD8 ratio (0.2, normal 1.05 to 2.61). Although the initial evaluation showed aberrations in T-cell subsets, they normalized with resolution of the CMV infection. The patient was discharged on the 50th day to complete 6 weeks of ganciclovir. She has remained well during the follow-up period of 9 months.</p>
</sec>
<sec id="section3-0009922811398962" sec-type="discussion">
<title>Discussion</title>
<p>CMV is a common human infection as evidenced by seroprevalence rates of 40% to 100% in adults.<sup><xref ref-type="bibr" rid="bibr1-0009922811398962">1</xref></sup> Most primary infections occur early in life and are asymptomatic or present as a mild mononucleosis-like syndrome.<sup><xref ref-type="bibr" rid="bibr2-0009922811398962">2</xref>,<xref ref-type="bibr" rid="bibr5-0009922811398962">5</xref></sup> Following acute infection, CMV becomes latent, putting the host at risk for recurrence. Reactivation is typically associated with immune dysfunction including congenital or acquired immune deficiency, transplant recipients, immunosuppressant therapy, and immune modulating diseases (diabetes mellitus, age &gt;55 years, renal failure, malignancy, lupus).<sup><xref ref-type="bibr" rid="bibr2-0009922811398962">2</xref>,<xref ref-type="bibr" rid="bibr4-0009922811398962">4</xref>,<xref ref-type="bibr" rid="bibr6-0009922811398962">6</xref>,<xref ref-type="bibr" rid="bibr7-0009922811398962">7</xref></sup> However, disease due to CMV reactivation does occur in immunocompetent individuals. In a large prospective study of nearly 8000 immunocompetent adults, disease due to CMV was found in 1.6%; the most common presentation being hepatitis (28%).<sup><xref ref-type="bibr" rid="bibr8-0009922811398962">8</xref></sup> In another study addressing GI involvement specifically, GI biopsies from unselected patients were screened for the presence of CMV; the overall prevalence of infection was 0.9%.<sup><xref ref-type="bibr" rid="bibr9-0009922811398962">9</xref></sup> In this study, the majority of patients with CMV were immunocompromised (69%), whereas 31% were immunocompetent.<sup><xref ref-type="bibr" rid="bibr9-0009922811398962">9</xref></sup> Pediatric patients constitute a small percentage of reported cases of CMV disease in immunocompetent patients.<sup><xref ref-type="bibr" rid="bibr4-0009922811398962">4</xref>,<xref ref-type="bibr" rid="bibr7-0009922811398962">7</xref>,<xref ref-type="bibr" rid="bibr8-0009922811398962">8</xref>,<xref ref-type="bibr" rid="bibr10-0009922811398962">10</xref>,<xref ref-type="bibr" rid="bibr11-0009922811398962">11</xref></sup></p>
<p>CMV disease can occur anywhere within the alimentary canal<sup><xref ref-type="bibr" rid="bibr12-0009922811398962">12</xref>-<xref ref-type="bibr" rid="bibr14-0009922811398962">14</xref></sup>; the most commonly involved site being the colon.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref>,<xref ref-type="bibr" rid="bibr4-0009922811398962">4</xref>,<xref ref-type="bibr" rid="bibr7-0009922811398962">7</xref>,<xref ref-type="bibr" rid="bibr12-0009922811398962">12</xref></sup> Small bowel involvement is relatively rare, with the distal small bowel being more commonly involved then the upper small bowel.<sup><xref ref-type="bibr" rid="bibr12-0009922811398962">12</xref>,<xref ref-type="bibr" rid="bibr15-0009922811398962">15</xref></sup> Symptoms depend on the location of the disease within the GI tract, as well as confounding factors in immunocompromised patients. Commonly described symptoms and signs are nonspecific, including fever, anorexia, nausea, vomiting, weight loss, abdominal pain, diarrhea, hematochezia, melena, and perforation.<sup><xref ref-type="bibr" rid="bibr4-0009922811398962">4</xref></sup> Endoscopic findings are typically represented by erosions, ulcerations, or hemorrhage of the mucosa<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref>,<xref ref-type="bibr" rid="bibr9-0009922811398962">9</xref>,<xref ref-type="bibr" rid="bibr10-0009922811398962">10</xref></sup>; rarely the mucosa may only appear erythematous, edematous, or normal.<sup><xref ref-type="bibr" rid="bibr10-0009922811398962">10</xref>,<xref ref-type="bibr" rid="bibr16-0009922811398962">16</xref>,<xref ref-type="bibr" rid="bibr17-0009922811398962">17</xref></sup></p>
<p>CMV inclusion bodies and/or positive immunohistochemical staining for CMV antigen on biopsy are considered the gold standard for diagnosing CMV enterocolitis.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> Supportive tests include serum anti-CMV antibodies (IgG and IgM), blood culture, stool culture, and oropharnygeal culture.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> Polymerase chain reaction is highly specific, but because of the transient nature of the viremia, a sample collected during time of dormancy for the virus can lead to false negative results.<sup><xref ref-type="bibr" rid="bibr18-0009922811398962">18</xref></sup> The patient described herein had CMV confirmed by the presence of inclusion bodies on mucosal biopsy, a positive stool culture, and positive serologic testing for CMV antibodies (IgM and IgG). Although CMV inclusion bodies can be present in infection without overt disease,<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> the marked improvement seen in our patient following treatment with ganciclovir supports a diagnosis of CMV-induced enteritis.</p>
<p>Investigation for an underlying immune deficiency in our patient was negative. However, an aberration in T-cell expression was noted with a decrease in T-helper cells, an increase in T suppressor-cytotoxic cells, and a reversal of the normal CD4:CD8 ratio. Follow-up studies performed 5 weeks after initiation of treatment showed near normalization of T-cell status. The finding of transient T-cell suppression during acute CMV infection, with subsequent normalization with improved clinical status, has been previously reported.<sup><xref ref-type="bibr" rid="bibr19-0009922811398962">19</xref></sup> Previous studies have shown that the risk for CMV colitis in immunocompromised individuals, particularly those with AIDS, directly correlates with decreased T-helper counts.<sup><xref ref-type="bibr" rid="bibr20-0009922811398962">20</xref></sup></p>
<p>CMV disease in immunocompetent patients is almost always self-limited, requiring only supportive care.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> Also, patients receiving immunosuppressant medications (corticosteroids, cancer chemotherapy, transplant recipients) have resolution of CMV infection if their medications can be decreased or stopped.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> GI CMV disease in sustained immunodeficiency has a high mortality rate if not treated.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> Predictors of increased mortality include advanced age, comorbid diagnoses, multi-organ involvement, and hospital-acquired infection.<sup><xref ref-type="bibr" rid="bibr8-0009922811398962">8</xref>,<xref ref-type="bibr" rid="bibr11-0009922811398962">11</xref></sup></p>
<p>However, in severe disease, regardless of underlying immune status, antiviral therapy may be warranted.<sup><xref ref-type="bibr" rid="bibr10-0009922811398962">10</xref>,<xref ref-type="bibr" rid="bibr21-0009922811398962">21</xref></sup> The drug of choice for severe CMV-induced colitis is gancyclovir for 2 to 6 weeks based on resolution of clinical signs and symptoms.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref>,<xref ref-type="bibr" rid="bibr4-0009922811398962">4</xref>,<xref ref-type="bibr" rid="bibr8-0009922811398962">8</xref>,<xref ref-type="bibr" rid="bibr11-0009922811398962">11</xref>,<xref ref-type="bibr" rid="bibr18-0009922811398962">18</xref></sup> Foscarnet may be used as a second-line agent but carries a higher risk for renal dysfunction and electrolyte abnormalities.<sup><xref ref-type="bibr" rid="bibr3-0009922811398962">3</xref></sup> Documenting resolution is possible by repeat colonoscopic biopsy or stool culture; however, it is typically not necessary.</p>
<p>In conclusion, we report an immunocompetent child who developed significant CMV enterocolitis requiring treatment with antiviral medication. CMV infection was entertained after more common etiologic organisms were excluded. Similar to previously reported patients, the patient described herein had a transient aberration in T-cell subsets. Despite its extreme rarity within the pediatric population, CMV infection should be considered in children with enteritis when more common etiologies have been excluded. A higher index of suspicion is indicated in immunocompromised patients; however, CMV colitis can be seen in individuals with normal immune function. Therapy is typically confined to supportive care, with antiviral treatment reserved for those with severe disease.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared no potential conflicts of interests with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The authors received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0009922811398962">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de la Hoz</surname><given-names>RE</given-names></name>
<name><surname>Stephens</surname><given-names>G</given-names></name>
<name><surname>Sherlock</surname><given-names>C</given-names></name>
</person-group>. <article-title>Diagnosis and treatment approaches of CMV infections in adult patients</article-title>. <source>J Clin Virol</source>. <year>2002</year>;<volume>25</volume>(<issue>Suppl 2</issue>):<fpage>S1</fpage>-<lpage>S12</lpage>.</citation>
</ref>
<ref id="bibr2-0009922811398962">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carter</surname><given-names>D</given-names></name>
<name><surname>Olchovsky</surname><given-names>D</given-names></name>
<name><surname>Pokroy</surname><given-names>R</given-names></name>
<name><surname>Ezra</surname><given-names>D</given-names></name>
</person-group>. <article-title>Cytomegalovirus-associated colitis causing diarrhea in an immunocompetent patient</article-title>. <source>World J Gastroenterol</source>. <year>2006</year>;<volume>12</volume>:<fpage>6898</fpage>-<lpage>6899</lpage>.</citation>
</ref>
<ref id="bibr3-0009922811398962">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goodgame</surname><given-names>RW</given-names></name>
</person-group>. <article-title>Gastrointestinal cytomegalovirus disease</article-title>. <source>Ann Intern Med</source>. <year>1993</year>;<volume>119</volume>:<fpage>924</fpage>-<lpage>935</lpage>.</citation>
</ref>
<ref id="bibr4-0009922811398962">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rafailidis</surname><given-names>PI</given-names></name>
<name><surname>Mourtzoukou</surname><given-names>EG</given-names></name>
<name><surname>Vorbobitis</surname><given-names>IC</given-names></name>
<name><surname>Falagas</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review</article-title>. <source>Virol J</source>. <year>2008</year>;<volume>6</volume>:<fpage>47</fpage>.</citation>
</ref>
<ref id="bibr5-0009922811398962">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ho</surname><given-names>M</given-names></name>
</person-group>. <article-title>Epidemiology of cytomegalovirus infections</article-title>. <source>Rev Infect Dis</source>. <year>1990</year>;<volume>12</volume>(<issue>Suppl 7</issue>):<fpage>S701</fpage>-<lpage>S710</lpage>.</citation>
</ref>
<ref id="bibr6-0009922811398962">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bang</surname><given-names>S</given-names></name>
<name><surname>Park</surname><given-names>YB</given-names></name>
<name><surname>Kang</surname><given-names>BS</given-names></name>
<etal/>
</person-group>. <article-title>CMV enteritis causing ileal perforation in underlying lupus enteritis</article-title>. <source>Clin Rheumatol</source>. <year>2004</year>;<volume>23</volume>:<fpage>69</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr7-0009922811398962">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Galiatsatos</surname><given-names>P</given-names></name>
<name><surname>Shrier</surname><given-names>I</given-names></name>
<name><surname>Lamoureux</surname><given-names>E</given-names></name>
<name><surname>Szilagyi</surname><given-names>A</given-names></name>
</person-group>. <article-title>Meta-analysis of outcome cytomegalovirus in immunocompetent hosts</article-title>. <source>Dig Dis Sci</source>. <year>2005</year>;<volume>50</volume>:<fpage>609</fpage>-<lpage>616</lpage>.</citation>
</ref>
<ref id="bibr8-0009922811398962">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wreghitt</surname><given-names>TG</given-names></name>
<name><surname>Teare</surname><given-names>EL</given-names></name>
<name><surname>Sule</surname><given-names>O</given-names></name>
<name><surname>Devi</surname><given-names>R</given-names></name>
<name><surname>Rice</surname><given-names>P</given-names></name>
</person-group>. <article-title>Cytomegalovirus infection in immunocompetent patients</article-title>. <source>Clin Infect Dis</source>. <year>2003</year>;<volume>37</volume>:<fpage>1603</fpage>-<lpage>1606</lpage>.</citation>
</ref>
<ref id="bibr9-0009922811398962">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Patra</surname><given-names>S</given-names></name>
<name><surname>Samal</surname><given-names>SC</given-names></name>
<name><surname>Chacko</surname><given-names>A</given-names></name>
<name><surname>Mathan</surname><given-names>VI</given-names></name>
<name><surname>Mathan</surname><given-names>MM</given-names></name>
</person-group>. <article-title>Cytomegalovirus infection of the human gastrointestinal tract</article-title>. <source>J Gastroenterol Hepatol</source>. <year>1999</year>;<volume>14</volume>:<fpage>973</fpage>-<lpage>976</lpage>.</citation>
</ref>
<ref id="bibr10-0009922811398962">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ng</surname><given-names>FH</given-names></name>
<name><surname>Chau</surname><given-names>TN</given-names></name>
<name><surname>Cheung</surname><given-names>TC</given-names></name>
<etal/>
</person-group>. <article-title>Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency</article-title>. <source>Dig Dis Sci</source>. <year>1999</year>;<volume>44</volume>:<fpage>945</fpage>-<lpage>952</lpage>.</citation>
</ref>
<ref id="bibr11-0009922811398962">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karakozis</surname><given-names>S</given-names></name>
<name><surname>Gongora</surname><given-names>E</given-names></name>
<name><surname>Caceres</surname><given-names>M</given-names></name>
<name><surname>Brun</surname><given-names>E</given-names></name>
<name><surname>Cook</surname><given-names>JW</given-names></name>
</person-group>. <article-title>Life-threatening cytomegalovirus colitis in the immunocompetent patient: report of a case and review of the literature</article-title>. <source>Dis Colon Rectum</source>. <year>2001</year>;<volume>44</volume>:<fpage>1716</fpage>-<lpage>1720</lpage>.</citation>
</ref>
<ref id="bibr12-0009922811398962">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buckner</surname><given-names>FS</given-names></name>
<name><surname>Pomeroy</surname><given-names>C</given-names></name>
</person-group>. <article-title>Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS</article-title>. <source>Clin Infect Dis</source>. <year>1993</year>;<volume>17</volume>:<fpage>644</fpage>-<lpage>656</lpage>.</citation>
</ref>
<ref id="bibr13-0009922811398962">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheung</surname><given-names>AN</given-names></name>
<name><surname>Ng</surname><given-names>IO</given-names></name>
</person-group>. <article-title>Cytomegalovirus infection of the gastrointestinal tract in non-AIDS patients</article-title>. <source>Am J Gastroenterol</source>. <year>1993</year>;<volume>88</volume>:<fpage>1882</fpage>-<lpage>1886</lpage>.</citation>
</ref>
<ref id="bibr14-0009922811398962">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klauber</surname><given-names>E</given-names></name>
<name><surname>Briski</surname><given-names>LE</given-names></name>
<name><surname>Khatib</surname><given-names>R</given-names></name>
</person-group>. <article-title>Cytomegalovirus colitis in the immunocompetent host: an overview</article-title>. <source>Scand J Infect Dis</source>. <year>1998</year>;<volume>30</volume>:<fpage>559</fpage>-<lpage>564</lpage>.</citation>
</ref>
<ref id="bibr15-0009922811398962">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Han</surname><given-names>KJ</given-names></name>
<name><surname>Jung</surname><given-names>IS</given-names></name>
<name><surname>Kim</surname><given-names>CK</given-names></name>
<etal/>
</person-group>. <article-title>A case of CMV disease of the jejunum in a patient with non-Hodgkin’s lymphoma</article-title>. <source>Korean J Intern Med</source>. <year>1998</year>;<volume>13</volume>:<fpage>143</fpage>-<lpage>146</lpage>.</citation>
</ref>
<ref id="bibr16-0009922811398962">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koriyama</surname><given-names>N</given-names></name>
<name><surname>Fukumoto</surname><given-names>O</given-names></name>
<name><surname>Fukudome</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Successful treatment of Good syndrome with cytomegalovirus duodenoenteritis using a combination of ganciclovir and immunoglobulin with high anti-cytomegalovirus antibody titer</article-title>. <source>Am J Med Sci</source>. <year>2004</year>;<volume>327</volume>:<fpage>49</fpage>-<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr17-0009922811398962">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franzin</surname><given-names>G</given-names></name>
<name><surname>Muolo</surname><given-names>A</given-names></name>
<name><surname>Griminelli</surname><given-names>T</given-names></name>
</person-group>. <article-title>Cytomegalovirus inclusions in the gastroduodenal mucosa of patients after renal transplantation</article-title>. <source>Gut</source>. <year>1981</year>;<volume>22</volume>:<fpage>698</fpage>-<lpage>701</lpage>.</citation>
</ref>
<ref id="bibr18-0009922811398962">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carney</surname><given-names>WP</given-names></name>
<name><surname>Rubin</surname><given-names>RH</given-names></name>
<name><surname>Hoffman</surname><given-names>RA</given-names></name>
<name><surname>Hansen</surname><given-names>WP</given-names></name>
<name><surname>Healey</surname><given-names>K</given-names></name>
<name><surname>Hirsch</surname><given-names>MS</given-names></name>
</person-group>. <article-title>Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis</article-title>. <source>J Immunol</source>. <year>1981</year>;<volume>126</volume>: <fpage>2114</fpage>-<lpage>2116</lpage>.</citation>
</ref>
<ref id="bibr19-0009922811398962">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abdulhannan</surname><given-names>P</given-names></name>
<name><surname>Sugarman</surname><given-names>ID</given-names></name>
<name><surname>Wood</surname><given-names>P</given-names></name>
<name><surname>Puntis</surname><given-names>J</given-names></name>
</person-group>. <article-title>Primary CMV colitis in an immunocompetent infant, successfully treated by gancyclovir</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. <year>2008</year>; <volume>47</volume>:<fpage>203</fpage>-<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr20-0009922811398962">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Drew</surname><given-names>WL</given-names></name>
</person-group>. <article-title>Cytomegalovirus infection in patients with AIDS</article-title>. <source>J Infect Dis</source>. <year>1988</year>;<volume>158</volume>:<fpage>449</fpage>-<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr21-0009922811398962">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hinds</surname><given-names>R</given-names></name>
<name><surname>Brueton</surname><given-names>MJ</given-names></name>
<name><surname>Francis</surname><given-names>N</given-names></name>
<name><surname>Fell</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Another cause of bloody diarrhea in infancy: cytomegalovirus colitis in an imunocompetent child</article-title>. <source>J Paediatr Child Health</source>. <year>2004</year>;<volume>40</volume>: <fpage>581</fpage>-<lpage>582</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>